Xiangjiao Meng

14PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyTumour immunologyMolecular targetsRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 14, 2026
Tambotatug Pelitecan in Small-Cell Lung Cancer after Platinum-Based Therapy.

|Apr 22, 2026
Opportunities and challenges of immunotherapy for patients with resectable and potentially resectable stage III non-small cell lung cancer.

|Oct 22, 2025
Sacituzumab Tirumotecan in EGFR-TKI-Resistant, EGFR-Mutated Advanced NSCLC.

Wenfeng Fang, Lin Wu, Xiangjiao Meng

|Apr 07, 2025
Application and future prospects of bispecific antibodies in the treatment of non-small cell lung cancer.

Junxu Wen, Wenxing Cui, Xiaoyan Yin

|Feb 06, 2024
Chemotherapy-free radiotherapy combined with immune checkpoint inhibitors: a new regimen for locally advanced non-small cell lung cancer?

Lin Ma, Liufu Deng, Jianfeng Peng

|Jul 06, 2022
TIGIT blockade enhances tumor response to radiotherapy via a CD103 + dendritic cell-dependent mechanism.

Kaikai Zhao, Liyang Jiang, Youjiao Si

Pageof 3

Frequent Collaborators

2 joint publications

Jinming Yu

2 joint publications

Jiuwei Cui

2 joint publications

Zhaoqin Huang

1 joint publications

Liangchao Sun